Iridex Appoints Patrick Mercer as Chief Executive Officer
03 oct. 2024 16h05 HE
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
Iridex Reports Second Quarter 2024 Financial Results
08 août 2024 16h05 HE
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
Iridex Announces Convertible Note Financing
05 août 2024 08h00 HE
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- IRIDEX Corporation (“Iridex”, or the “Company”) (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical...
Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024
30 juil. 2024 16h05 HE
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
Iridex Reports First Quarter 2024 Financial Results
14 mai 2024 16h05 HE
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
Iridex to Report First Quarter 2024 Financial Results on May 14, 2024
08 mai 2024 16h05 HE
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
26 mars 2024 16h05 HE
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
20 mars 2024 16h05 HE
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
Iridex Corporation Receives European Patent on MicroPulse Technology
06 févr. 2024 08h00 HE
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust
24 janv. 2024 08h00 HE
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation, headquartered in Mountain View, California, and Imperial College Healthcare NHS Trust in London, today announced the...